Nexvet Biopharma PLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nexvet Biopharma PLC
CIK #0001618561
EDGAR Form CIK 2011 - 2026
10-K [0001618561]
10-Q [0001618561]
3 [0001618561]
4 [0001618561]
8-K [0001618561]
SC 13D [0001618561]
SC 13G [0001618561]
Form 13D/13G Filer Form 13D/13G Subject Filed
AustralianSuper PTY Ltd Nexvet Biopharma PLC [2017-01-11]
Bioscience Managers PTY Ltd Nexvet Biopharma PLC [2016-02-16]
Broadfin Capital LLC Nexvet Biopharma PLC [2015-12-28]
Wellington Management Group LLP Nexvet Biopharma PLC [2015-03-10]
Farallon Capital Management LLC Nexvet Biopharma PLC [2015-02-20]
Adage Capital Partners GP LLC Nexvet Biopharma PLC [2015-02-17]
Foresite Capital Fund II LP Nexvet Biopharma PLC [2015-02-11]
Form 3/4/5 Subject 2011 - 2026
Nexvet Biopharma PLC
Patel Rajiv A
Payne John Bernard
McCracken Joseph S
Lismore Damian T
Kilty Cormac G
Horn Jurgen
Heffernan Mark
Hanna Ashraf
Gunn George W
Farrell Geraldine T
Brown Christopher Nigel
Landry Monica R
Spokes Andrew J M
Paidipaty Ravi K
Fried Richard B
Linn Michael G
Warren John R
Wehrly Mark C
Roberts Thomas G Jr
Seybold William
Kim David T
Fisch Michael B
Farallon Partners GP VI LLC
Akubra Investors LLC
Bushranger Funding LLC
Ute Holdings LLC
Dreyfuss Philip D
NGP LLC
Farallon AA GP LLC
Farallon Capital Management LLC
Farallon Partners L L C/CA
Hirsch Daniel J
Gearing David
Giles Colin
Wald Graeme
Adage Capital Partners GP LLC
Adage Capital Partners LP
Adage Capital Advisors LLC
Atchinson Robert
Gross Phillip
One Funds Management Ltd ATF Asia Pacific Healthcare Fund II
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
2017-07-31 Disposed to issuer 30,000 $6.60 198,000
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Disposed to issuer 1,500 $6.72 10,080
Nexvet Biopharma PLC NVET
Option to Purchase Ordinary Shares · derivative
2017-07-31 Disposed to issuer 52,040 $0.37 19,255
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Disposed to issuer 18,724 $6.72 125,825
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 209,577 $6.72 1,408,357
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Disposed to issuer 18,980 $6.72 127,546
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
2017-07-31 Disposed to issuer 1,000 $6.60 6,600
Nexvet Biopharma PLC NVET
Options to purchase ordinary shares · derivative
2017-07-31 Disposed to issuer 7,080 $6.60 46,728
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
2017-07-31 Disposed to issuer 50,000 $6.60 330,000
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Disposed to issuer 243,587 $6.72 1,636,905
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 899,268 $6.72 6,043,081
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
2017-07-31 Disposed to issuer 47,250 $6.60 311,850
Nexvet Biopharma PLC NVET
Option to Purchase Shares · derivative
2017-07-31 Disposed to issuer 100,000 $0.00
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 122,006 $6.72 819,880
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Disposed to issuer 7,200 $6.72 48,384
Nexvet Biopharma PLC NVET
Options to purchase ordinary shares · derivative
2017-07-31 Disposed to issuer 3,600 $6.60 23,760
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 833,845 $6.72 5,603,438
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 209,577 $6.72 1,408,357
Nexvet Biopharma PLC NVET
Option to Purchase Ordinary Shares · derivative
2017-07-31 Disposed to issuer 100,000 $0.00
Nexvet Biopharma PLC NVET
Ordinary Shares
2017-07-31 Tender 2,648,696 $6.72 17,799,237
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com